Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03078413 · ClinicalTrials.gov registry record
Late Function After Surgery for Transposition of the Great Arteries
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 45
- Enrollment target
NCT03078413: Completed study, sponsored by Indiana University.
NCT03078413 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03078413 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The investigators proposed to review the exercise tolerance, cardiac function, and quality of life in patients born with transposition of the great arteries that have undergone surgery with either the Mustard or Senning procedure. Participants will complete a questionnaire. The investigators will review the participants' recent cardiac function testing which will assess their current health status. These tests include an echocardiogram, a metabolic exercise stress test, cardiac imaging, and a 24-hour Holter monitor. This collection of testing results will be compared specifically with previously acquired data during the first phases of this study (published in 2001 and 2007).
Primary Outcome
Survival following Mustard procedure to time of study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2017-03-03 |
| Est. Completion | 2018-06-30 |
What the finished NCT03078413 record still lists
NCT03078413 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03078413 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03078413 about?
NCT03078413 is a clinical study titled "Late Function After Surgery for Transposition of the Great Arteries". The investigators proposed to review the exercise tolerance, cardiac function, and quality of life in patients born with transposition of the great arteries that have undergone surgery with either the Mustard or Senning procedure. Participants will complete a questionnaire. The investigators will re...
What is the current status of trial NCT03078413?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2017-03-03. Estimated completion is 2018-06-30.
Who is sponsoring clinical trial NCT03078413?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI